Chief Executive Officer at Phamaceutical Manufacturing Unit- Eastbourne Pharmaceuticals(NHS) - , ,
The manufacturing unit at Eastbourne has recently been refurbished and with new people in place, together with an excellent support team, we are now poised to improve our service levels and move towards operating on a more commercial basis, making our services available to a wider market.With a turnover of £4 million, the unit currently produces a large range of sterile and non-sterile products and provides a pre-packing and over-labelling service to a large range of both NHS and private customers. (Overall some 1,500 presentations). Our aim is to be recognised as the best NHS supply point for ‘specials', measured against response and supply times by 2011.We are currently looking at developing our services to include rapid response extemporaneous dispensing and clinical trial material manufacture and would welcome enquiries in these areas.